Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125018912 | 12501891 | 2 | F | 20160628 | 20160627 | 20160707 | EXP | IT-DEPOMED, INC.-IT-2016DEP011223 | DEPOMED | MARTINO EA, WINTERTON D, NARDELLI P, PASIN L, CALABRO MG, BOVE T, ET AL.. THE BLUE COMA: THE ROLE OF METHYLENE BLUE IN UNEXPLAINED COMA AFTER CARDIAC SURGERY. JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA. 2016;30(2):423-427 | 74.00 | YR | F | Y | 78.00000 | KG | 20160707 | MD | IT | IT |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125018912 | 12501891 | 1 | PS | FENTANYL CITRATE. | FENTANYL CITRATE | 1 | Intravenous (not otherwise specified) | 250 ?G, UNK | 22569 | 250 | UG | ||||||||
125018912 | 12501891 | 2 | SS | FENTANYL CITRATE. | FENTANYL CITRATE | 1 | Intravenous (not otherwise specified) | 750 ?G, UNK | 22569 | 750 | UG | ||||||||
125018912 | 12501891 | 3 | SS | FENTANYL CITRATE. | FENTANYL CITRATE | 1 | Intravenous (not otherwise specified) | 700 ?G, UNK | 22569 | 700 | UG | ||||||||
125018912 | 12501891 | 4 | SS | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | Oral | 25 MG, UNK | U | 0 | 25 | MG | |||||||
125018912 | 12501891 | 5 | SS | METHYLENE BLUE. | METHYLENE BLUE | 1 | Intravenous (not otherwise specified) | 100 MG, OVER 20 MINUTES, TWICE | 0 | 100 | MG | SOLUTION FOR INJECTION | |||||||
125018912 | 12501891 | 6 | SS | AMISULPRIDE | AMISULPRIDE | 1 | UNK | U | 0 | ||||||||||
125018912 | 12501891 | 7 | SS | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | UNK | U | 0 | ||||||||||
125018912 | 12501891 | 8 | C | PROPOFOL. | PROPOFOL | 1 | 100 MG, UNK | 0 | 100 | MG | |||||||||
125018912 | 12501891 | 9 | C | PROPOFOL. | PROPOFOL | 1 | 962 MG, UNK | 0 | 962 | MG | |||||||||
125018912 | 12501891 | 10 | C | ROCURONIUM | ROCURONIUM BROMIDE | 1 | 50 MG, UNK | 0 | 50 | MG | |||||||||
125018912 | 12501891 | 11 | C | ROCURONIUM | ROCURONIUM BROMIDE | 1 | 170 MG, UNK | 0 | 170 | MG | |||||||||
125018912 | 12501891 | 12 | C | SEVOFLURANE. | SEVOFLURANE | 1 | 0.5-1 MAC/HR | 0 | |||||||||||
125018912 | 12501891 | 13 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | UNK | U | 0 | ||||||||||
125018912 | 12501891 | 14 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | UNK | U | 0 | ||||||||||
125018912 | 12501891 | 15 | C | GABAPENTIN. | GABAPENTIN | 1 | UNK | U | 0 | ||||||||||
125018912 | 12501891 | 16 | C | VITAMIN D /00107901/ | ERGOCALCIFEROL | 1 | UNK | U | 0 | ||||||||||
125018912 | 12501891 | 17 | C | FUROSEMIDE. | FUROSEMIDE | 1 | UNK | U | 0 | ||||||||||
125018912 | 12501891 | 18 | C | SIMVASTATIN. | SIMVASTATIN | 1 | UNK | U | 0 | ||||||||||
125018912 | 12501891 | 19 | C | CANRENONE | CANRENONE | 1 | UNK | U | 0 | ||||||||||
125018912 | 12501891 | 20 | C | FOLIN /00024201/ | FOLIC ACID | 1 | UNK | U | 0 | ||||||||||
125018912 | 12501891 | 21 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | UNK | U | 0 | ||||||||||
125018912 | 12501891 | 22 | C | ALLOPURINOL. | ALLOPURINOL | 1 | UNK | U | 0 | ||||||||||
125018912 | 12501891 | 23 | C | PREDNISONE. | PREDNISONE | 1 | UNK | U | 0 | ||||||||||
125018912 | 12501891 | 24 | C | METHOTREXATE. | METHOTREXATE | 1 | UNK | U | 0 | ||||||||||
125018912 | 12501891 | 25 | C | NITROGLYCERIN. | NITROGLYCERIN | 1 | UNK | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125018912 | 12501891 | 1 | General anaesthesia |
125018912 | 12501891 | 4 | Depression |
125018912 | 12501891 | 5 | Vasoplegia syndrome |
125018912 | 12501891 | 6 | Product used for unknown indication |
125018912 | 12501891 | 7 | Product used for unknown indication |
125018912 | 12501891 | 8 | Anaesthesia |
125018912 | 12501891 | 10 | Anaesthesia |
125018912 | 12501891 | 12 | Anaesthesia |
125018912 | 12501891 | 13 | Product used for unknown indication |
125018912 | 12501891 | 14 | Product used for unknown indication |
125018912 | 12501891 | 15 | Product used for unknown indication |
125018912 | 12501891 | 16 | Product used for unknown indication |
125018912 | 12501891 | 17 | Product used for unknown indication |
125018912 | 12501891 | 18 | Product used for unknown indication |
125018912 | 12501891 | 19 | Product used for unknown indication |
125018912 | 12501891 | 20 | Product used for unknown indication |
125018912 | 12501891 | 21 | Product used for unknown indication |
125018912 | 12501891 | 22 | Product used for unknown indication |
125018912 | 12501891 | 23 | Product used for unknown indication |
125018912 | 12501891 | 24 | Product used for unknown indication |
125018912 | 12501891 | 25 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125018912 | 12501891 | LT |
125018912 | 12501891 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125018912 | 12501891 | Agitation | |
125018912 | 12501891 | Cardiogenic shock | |
125018912 | 12501891 | Coma | |
125018912 | 12501891 | Drug interaction | |
125018912 | 12501891 | Extrapyramidal disorder | |
125018912 | 12501891 | Hyperreflexia | |
125018912 | 12501891 | Multiple organ dysfunction syndrome | |
125018912 | 12501891 | Nystagmus | |
125018912 | 12501891 | Sepsis | |
125018912 | 12501891 | Serotonin syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |